Page 10 - SaxoCell Annual Report22/23

SaxoCell in portrait

Achieving more together

SaxoCell - the Saxon precision therapy cluster aims to
provide effective, safe and affordable autologous and
allogeneic cell and gene therapies to patients suffering
from difficult-to-treat diseases.

In doing so, we bring together excellent basic as well as
applied research expertise within Saxony with industrial
resources and the know-how of other national and
international partners to become a beacon for cell and
gene therapy in Europe. Core institutions of SaxoCell

Our core partners are the TUD
Dresden University of Techno-
NATIONAL REGIONAL logy, the University of Leipzig,
the Fraunhofer Institute for
ecSeq
Miltenyi bioinformatics Cell Therapy and Immunology
Biotec and the Chemnitz Hospital. In
T-Cell Cell.Copedia DKMS
Tolerance Life Science Lab addition, eight industrial
Leipzig partners are already working
T-CURX MDTB Cells closely with SaxoCell.
Dresden
SaxoCell is one of seven
winners of the nationwide
Affimed Chemnitz
Clusters4Future initiative of
the BMBF and is funded with
approximately EUR 15 million
for the first implementation
Industry partner of SaxoCell phase 2021 - 2024.
5